Anemia
News
Drug can improve upon chelation therapy in thalassemia major
An anti-hypertensive drug can improve the effects of chelation therapy in patients with thalassemia major and cardiac iron overload, according to...
Conference Coverage
HU trial to prevent stroke in SCA feasible in Nigeria
© Todd Buchanan 2016 SAN DIEGO—High rates of recruitment (90%), enrollment (92%), and adherence to study drug and follow-up visits have confirmed...
News
Drug granted fast track designation for PNH
The US Food and Drug Administration (FDA) has granted fast track designation for the complement C3 inhibitor APL-2. The designation applies to...
News
Agios stops developing drug for PK deficiency
Agios Pharmaceuticals, Inc.
Conference Coverage
MDS patients with mutated IDH2 benefit from enasidenib
Photo courtesy of ASH SAN DIEGO—Daily treatment with enasidenib monotherapy in patients with mutated IDH2-positive myelodysplastic syndromes (MDS...
News
Predicting the risk of CKD in sickle cell anemia
and normal red blood cells Image by Graham Beards Researchers say they have identified a genetic risk profile that can be used to predict which...
Conference Coverage
Predicting therapy-related myeloid neoplasms
Photo courtesy of MD Anderson Cancer Center SAN DIEGO―Clonal hematopoiesis could be used as a predictive marker to identify cancer patients at...
Conference Coverage
Another treatment on the horizon for SCD
Photo courtesy of ASH SAN DIEGO—The first-in-class humanized anti-P-selectin antibody SelG1, also known as crizanlizumab, significantly reduced...
News
Fanconi anemia linked to cancer gene
Researchers say they have discovered an important molecular link between Fanconi anemia (FA) and PTEN, a gene associated with uterine, prostate,...
Conference Coverage
VIDEO: SPIN tests hydroxyurea to prevent pediatric stroke in sickle cell disease
SAN DIEGO - Whether hydroxyurea can avert a first stroke in children with sickle cell disease is a question that may be answered by a soon-to-be-...
Conference Coverage
Herbal medicine can reduce pain, fatigue in SCD patients
Convention Center, site of the 2016 ASH Annual Meeting SAN DIEGO—Results of a phase 1 study suggest that SCD-101, a botanical extract based on an...